News | | Terumo

December 04, 2014

Corporate

Terumo receives CE Mark approval for the line extension on Drug-eluting Stent, Ultimaster® to advance the treatment of coronary artery disease

October 31, 2014

Corporate

Terumo Announces its Application for the Manufacture and Sales Approval of its Skeletal Myoblast Sheets - To Aim for the World's First Cardiac Regenerative Therapy

October 23, 2014

Corporate

Terumo transforms product portfolio of Hospital and Laboratory Business in Europe (PDF 177.35 KB)

September 23, 2014

Corporate

Terumo Cardiovascular Group to Distribute Nonin Medical’s SenSmart™ Model X-100 Universal Oximetry System in U.S. Cardiovascular Hospitals

August 08, 2014

Corporate

Announcement of a New Corporate Logo Mark

August 06, 2014

Financial

Notice Concerning the Issuance of Stock Option (Share Warrants) (PDF 56.35 KB)

May 20, 2014

Corporate

Terumo BCT Enters Agreement with Kaneka CorporationMulti-year collaboration agreement for the combined use of therapeutic apheresis and columns for LDL reduction

May 15, 2014

Corporate

Terumo® Launches Expanded GLIDEWAY™ Access Sheath Portfolio With A New Product For Minimally Invasive Urologic Procedures

New GLIDEWAY™ Ureteral Access Sheath Offers Advanced Features Designed to Minimize Trauma

May 08, 2014

Financial

Notice Concerning the Renewal of a Policy for Large-scale Acquisitions of Terumo Shares (Takeover Defense Measures) (PDF 129.84 KB)

April 24, 2014

Corporate

New Candidate for Independent Director

April 24, 2014

Corporate

Regarding the Result of Inspection at Terumo CVS Ann Arbor Plant by U.S. Food & Drug Administration (FDA)

April 02, 2014

Corporate

Terumo Expands Sales Collaboration in Japan with Biosensors for Nobori® DES and Extends Licensing Agreement to Sell the Product Overseas

March 27, 2014

Corporate

Election of New Board Members

March 25, 2014

Corporate

Terumo BCT Becomes Therakos Inc. Distributor in Latin America

Multi-year agreement enables Terumo BCT to provide Therakos products in several Latin American countries

March 14, 2014

Corporate

Terumo Announces Exclusive Acquisition Right Agreement with French Bioresorbable Scaffold Company, "ART"

February 12, 2014

Corporate

Terumo Wins Pharmapack 2014 Award For Nanopass® 34 Pen-Needle In The Category "Quality Of Life"

February 03, 2014

Corporate

Terumo Receives CE Mark for Its New Drug-eluting Stent, Ultimaster™

January 28, 2014

Corporate

Nonin Medical Announces U.K. and Ireland Distribution Agreement with Terumo Cardiovascular Group in Europe for Nonin's SenSmart™ Universal Oximetry System

January 28, 2014

Corporate

U.S. Food and Drug Administration Clears Granulocyte Collection Procedure on the Spectra Optia Apheresis System

Granulocyte, or polymorphonuclear [PMN] cell, collections on the next-generation therapeutic apheresis platform to optimize cellular collections and supplement current protocol offering

December 16, 2013

Corporate

U.S. FDA Clears Sickle Cell Disease Indication with New Red Blood Cell Exchange (RBCX) Protocol on the Spectra Optia® Apheresis System in the United States

RBCX protocol delivers ability to safely and effectively treat sickle cell disease in adults and children

November 29, 2013

Corporate

Terumo Acquires International Environmental and Health and Safety Certifications Promoting Global Management

November 18, 2013

Corporate

Announcement regarding a Settlement of Lawsuit against Olympus Corporation

November 18, 2013

Corporate

Terumo to Support Relief Efforts Following Philippines Typhoon Victims

Support with Donation and Medical Devices Worth 22 Million Japanese Yen

November 13, 2013

Corporate

Terumo BCT Releases Software 2.0 for Quantum® Cell Expansion System

Enhanced software supports cell therapy and research organizations with added value, compliance aid

October 31, 2013

Corporate

Terumo Establishes Local Sales Subsidiary and Accelerates Expansion in India

October 29, 2013

Corporate

Terumo Interventional Systems Expands Specialty Line of Glidewire® Advantage™ Peripheral Guidewires For Smaller Vessels

New 0.018" Wire Reduces Need for Multiple Wire Exchanges

October 21, 2013

Corporate

Terumo Medical Corporation Supports Breast Cancer Awareness

Terumo associates walked four laps around the corporate campus in their pink and denim in honor of Breast Cancer Awareness month

October 21, 2013

Corporate

Terumo BCT Awarded Cost-Share Contract Worth Up to $29.9M for Research and Development Effort with the U.S. Department of Defense

October 04, 2013

Corporate

Terumo Invests in U.S. Medtech Venture Capital Fund

July 22, 2013

Corporate

Microvention Announces First Trial Enrollment In Their U.S. Clinical Trial Of Its New Dual-Layer Stent For Cerebral Aneurysm Flow Diversion

July 15, 2013

Corporate

Terumo BCT Breaks Ground on New Vietnam Manufacturing Facility

July 01, 2013

Corporate

Terumo Enters Strategic Alliance for DuraHeart® II with Thoratec

June 30, 2013

Corporate

Multicenter Study Finds Cost Savings Associated With Coronary Interventions Via Transradial (Wrist) Access Exceed $800 Per Procedure Versus Transfemoral (Groin) Access

Researchers Say Transradial Procedures Could Help U.S. Hospitals Realize Nearly $50 Million in Annual Cost Savings with Only a Modest 10% Increase in Transradial Procedures

May 21, 2013

Corporate

Terumo Medical Corporation Obtains Withdrawal By Vascular Solutions Of The R-Band™ Radial Hemostasis Device

Court Enters Order Under Which Vascular Solutions Will Cease Manufacture, Sales and Distribution of R-Band

May 09, 2013

Financial

Terumo Introduces Stock Option as Stock-Based Compensation Plan

April 25, 2013

Corporate

Terumo Expands Peripheral Intervention Business Terumo Concludes Co-development Agreement for PTA Balloon Catheters with Kaneka Corporation

April 24, 2013

Corporate